Genotype-based clinical manifestation and treatment of Chinese long QT syndrome patients with KCNQ1 mutations - R380S and W305L

Cardiology in the Young
Hui ZhouKui Hong

Abstract

Aim Most long QT syndrome patients are associated with genetic mutations. We aimed to investigate the clinical and biochemical characteristics and look for genotype-based preventive implications in Chinese long QT syndrome patients. Methods and results We identified two missense mutations of the KCNQ1 gene in two independent Chinese families, including a previously reported mutation R380S in the C-terminus and a novel mutation W305L in the P-loop domain of the Kv7.1 channel, respectively. The proband with R380S was an 11-year-old girl who suffered a prolonged corrected QT interval of 660 ms, recurrent syncope, and sudden cardiac death, whose father was an asymptomatic carrier. The mutation W305L was detected in a 36-year-old woman with long QT syndrome and her immediate family members including the proband's younger sister with an unexplained syncope, her son, and her elder daughter without symptoms. Metoprolol appeared to be effective in preventing arrhythmias and syncope in long QT syndrome patients with mutation W305L. Both R380S and W305L mutations led to "loss-of-function" of the Kv7.1 channel accounting for the clinical phenotypes. We first show two missense KCNQ1 mutations - R380S and W305L - in Chinese long QT syndrome ...Continue Reading

References

Feb 18, 2004·Journal of Cardiac Failure·Thomas D GilesRobert Roberts
Jun 24, 2004·American Journal of Medical Genetics. Part a·Karen W GrippLinda Nicholson
Sep 25, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Mei ShuangDai Zhang
Apr 21, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·David J TesterMichael J Ackerman
May 8, 2007·Biochemical and Biophysical Research Communications·Nicole SchmittMartin Schwarz
Mar 6, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Kenji YasudaSeiji Yamaguchi
Sep 1, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Jamie D KapplingerMichael J Ackerman
Oct 21, 2009·Circulation·Peter J SchwartzCarla Spazzolini
Nov 16, 2011·Circulation·Peter J Schwartz, Lia Crotti
Aug 17, 2012·Circulation. Arrhythmia and Electrophysiology·Peter J SchwartzRoberto Insolia
Sep 22, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·John R Giudicessi, Michael J Ackerman
Oct 23, 2012·Journal of the American College of Cardiology·Priya ChockalingamArthur A M Wilde
Dec 26, 2012·Gene·Hugues Abriel, Elena V Zaklyazminskaya
Sep 27, 2014·Journal of the American College of Cardiology·Abeer Abu-ZeitoneArthur J Moss
Sep 27, 2014·Journal of the American College of Cardiology·Arthur A M Wilde, Michael J Ackerman
Oct 3, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Yuka MizusawaArthur A M Wilde

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.